Home arrow Drug Delivery arrow Injectable Drug Delivery: Probing the Route to Growth
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Drug Delivery arrow Injectable Drug Delivery: Probing the Route to Growth

Injectable Drug Delivery: Probing the Route to Growth


Price: $7 600.00



FREE BONUS REPORT(S): When you buy below report, you may pick 1 additional cancer report for free from this list
(Value: 2,468 USD)


Introduction

The injectable drug delivery market is growing. Rising 16.3% to an estimated $83 billion in 2002, it is forecast to grow at a CAGR of 10% between 2002 and 2008. The increasing use of reformulation techniques earlier in product lifecycles is changing the dynamics of the injectables field, and players will need to evolve if they are to capitalize on the opportunities offered by the growing market

Scope

  • Analysis of the injectables portfolio and pipeline for the top 40 pharmaceutical companies
  • Benchmarking of the current and future injectables market by technology and therapeutic focus
  • Full profiles of 6 leading injectable drug delivery players, encompassing company strategy, alliance network, and portfolio and pipeline analysis
  • Analysis of product sourcing and marketing strategies of 37 injectable drug delivery players

Highlights

Use of injectable drug delivery to optimize administration of the growing number of protein-based products and, as an effective lifecycle management tool in the increasingly competitive pharmaceutical market, is expected to drive strong growth of the injectables market over the next five years

Within the injectables market companies can position themselves as injectable specialists or multi-platform players, and can operate along the scale from technology service provider to fully integrated player. Specialists are well suited for a service provider strategy, while multi-platform players will benefit from moving toward full integration

Competition within the injectable drug delivery market is increasing as non-invasive methods of drug administration begin to encroach on traditionally injectable market areas. Injectable players must continue to develop or acquire new drug delivery technologies to maintain a competitive advantage

Reasons to Purchase

  • Benchmark your position within the injectable drug delivery market and identify the optimum strategy for future growth
  • Understand trends across technological and therapeutic fields to target resources effectively and recognize pipeline opportunities
  • Optimize your market penetration through comprehensive knowledge of the growth drivers and corporate dynamics of the injectable market

Pages: 176

Table of Contents

Download TOC in PDF




:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product













more categories

Companies


Featured Products


Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group